Jason Coloma V sold $1M of MAZE stock

Jason Coloma V, Chief Executive Officer of Maze Therapeutics, Inc. (MAZE), sold 34,501 shares of MAZE stock worth $1M, per an SEC Form 4 filed Nov 4, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Nov 2, 2026, 2 days before it was made public.

MAZE has moved +12.6% since the trade date, from $30.37 to $34.19 (Nov 6, 2026 close).